Key facts
- It has raised $3.1M; the latest was Accelerator/Incubator in Dec 2025.
- Notable investors include Plug and Play Tech Center, MassChallenge, StartLife, Siddhi Capital, Unruly Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Zya (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Zya (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zya (Biotechnology)
Producer of enzyme-based nutritional enhancers designed to improve the way the body processes food. The company utilises naturally-derived enzymes to convert sugar into dietary fiber during digestion, maintaining the original taste and texture of foods while providing improved nutritional outcomes, enabling food brands and consumers to access enhanced nutrition without altering their eating experience.
- Sector
- Healthcare
- HQ
- Wilmslow, United Kingdom
- Founded
- 2018
- Employees
- 10
- Website
- zya.co/
- Ownership
- Privately Held (backing)
Zya (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zya (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zya (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.